Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.

about

Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study.

Item

http://www.wikidata.org/entity/Q47140323

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@en

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@nl

type

Item

label

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@en

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@nl

prefLabel

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@en

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@nl

P1476

Fibrinogen and C-reactive prot ...... : a prognostic nomogram study.

@en

P2093

Chuyu Jing

http://www.w3.org/2001/XMLSchema#string

Jia Fan

http://www.w3.org/2001/XMLSchema#string

Jian Zhou

http://www.w3.org/2001/XMLSchema#string

Jinlong Huang

http://www.w3.org/2001/XMLSchema#string

Shuangjian Qiu

http://www.w3.org/2001/XMLSchema#string

Wei Gan

http://www.w3.org/2001/XMLSchema#string

Yipeng Fu

http://www.w3.org/2001/XMLSchema#string

Yong Yi

http://www.w3.org/2001/XMLSchema#string

Zhufeng Lu

http://www.w3.org/2001/XMLSchema#string

P2860

C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Recent advances in hepatocellular carcinoma therapy.

Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin.

Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients.

The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.

Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type

The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study

P304

148-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.22246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29290780

http://www.w3.org/2001/XMLSchema#string

P932

5743722

http://www.w3.org/2001/XMLSchema#string